Cargando…
FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration
Radiotherapy is one of the standard treatments for cervical cancer and head and neck cancer. However, the clinical efficacy of this treatment is limited by radioresistance. The discovery of effective prognostic biomarkers and the identification of new therapeutic targets have helped to overcome the...
Autores principales: | Li, Sisi, Huang, Xiao-ting, Wang, Meng-yao, Chen, Dong-ping, Li, Ming-yi, Zhu, Yan-yi, Yu, Yi, Zheng, Lu, Qi, Bin, Liu, Jin-quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264437/ https://www.ncbi.nlm.nih.gov/pubmed/34249689 http://dx.doi.org/10.3389/fonc.2021.653005 |
Ejemplares similares
-
PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014) -
Case Report: Kaposiform hemangioendothelioma with PIK3CA mutation successfully treated with sirolimus
por: Wang, Zuopeng, et al.
Publicado: (2023) -
Prevalence of PIK3CA mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysis
por: Chao, Ta-Chung, et al.
Publicado: (2023) -
Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification
por: Pai, Shih-Min, et al.
Publicado: (2021) -
PIK3CA Is Regulated by CUX1, Promotes Cell Growth and Metastasis in Bladder Cancer via Activating Epithelial-Mesenchymal Transition
por: Wang, Zhongyu, et al.
Publicado: (2020)